(Q40476302)

20 September 2017

title

What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria? (English)

1 reference

20 September 2017

Kelly M

1

1 reference

20 September 2017

Roy DC

series ordinal

2

1 reference

20 September 2017

Labbe AC

series ordinal

3

1 reference

20 September 2017

Laverdiere M

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

19 June 2006

1 reference

Bone Marrow Transplantation

20 September 2017

published in

1 reference

20 September 2017

volume

38

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

183-188

1 reference

Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

Does haploidentical transplantation in children with primary immunodeficiencies have the potential to exploit donor NK cell alloreactivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

Elimination of alloreactive T cells using photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

7 January 2021

Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

7 January 2021

Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

7 January 2021

P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705421

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705421

1 reference

Dimensions Publication ID

20 September 2017

1051978208

0 references

1 reference